Humana (HUM) Down 10.1% Since Last Earnings Report: Can It Rebound?

30.05.25 17:31 Uhr

Werte in diesem Artikel
Aktien

202,40 EUR -1,50 EUR -0,74%

Indizes

5.911,7 PKT -0,5 PKT -0,01%

A month has gone by since the last earnings report for Humana (HUM). Shares have lost about 10.1% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Humana due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended upward during the past month.The consensus estimate has shifted 8.2% due to these changes.VGM ScoresAt this time, Humana has a great Growth Score of A, though it is lagging a lot on the Momentum Score front with a C. However, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Humana has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Humana Inc. (HUM): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Humana und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Humana

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Humana

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Humana Inc.

Wer­bung

Analysen zu Humana Inc.

DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
09.11.2017Humana Sector PerformRBC Capital Markets
20.10.2017Humana OutperformBMO Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
DatumRatingAnalyst
12.08.2019Humana OverweightCantor Fitzgerald
13.09.2018Humana OverweightBarclays Capital
20.10.2017Humana OutperformBMO Capital Markets
24.01.2017Humana HoldStifel, Nicolaus & Co., Inc.
05.05.2016Humana BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
09.11.2017Humana Sector PerformRBC Capital Markets
05.04.2017Humana HoldDeutsche Bank AG
07.12.2016Humana HoldCantor Fitzgerald
13.10.2016Humana Sector PerformRBC Capital Markets
22.07.2016Humana Mkt PerformFBR Capital
DatumRatingAnalyst
14.03.2008Humana neues KurszielLehman Brothers Inc.
03.02.2006Update Humana Inc.: UnderperformCredit Suisse First Boston
26.01.2006Update Humana Inc.: ReduceUBS

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Humana Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen